Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan USA, Inc. et al v. MSN Laboratories Private Limited et al
Case Number:
1:21-cv-01064
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
November 03, 2022
IP Forecast: VLSI Patent Battle Against Intel Goes For Round 4
A fourth trial kicks off in Austin next week in a multibillion-dollar legal war between VLSI Technology and Intel over the licensing company's microchip technology patents. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
July 26, 2021
Allergan Hits Generic Cos. With Patent Suits Over Viberzi
Allergan USA Inc. has filed patent infringement suits in Delaware federal court to stop a number of Indian competitors from making generic versions of its irritable bowel syndrome drug Viberzi.